A dynamic leader in pharmaceutical contract manufacturing, born from the merger of Mipharm and Doppel, two renowned names in the industry.
We specialize in a full spectrum of development, from R&D to regulatory support, with a focus on compliance across all production stages. Our portfolio includes pharmaceuticals, supplements and cosmetic products. As part of our expanding group, we also include Alfa Omega, a player in dietary supplements and homeopathic medicines.
Committed to high standards of quality and safety, DMX PHARMA sets the pace for innovation in global healthcare.
Company Details
- Employees
- 17
- Founded
- 2024
- Address
- Milano, Italia, It
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.dmxpharma.com
- Keywords
- Pharmaceutical, Pharma, Farmaceutico, CDMO Pharma, CDMO, Medical Device, Homeopatic, Nutraceutical, Contract Manufacturing.
- HQ
- Milano, Italia
Dmx Pharma Questions
Dmx Pharma's website is http://www.dmxpharma.com
Dmx Pharma's LinkedIn profile is https://it.linkedin.com/company/dmx-pharmaceuticals
Dmx Pharma has
17 employees.
View email and phone details for 17
employees at Dmx Pharma.
Dmx Pharma's industry is
Pharmaceutical Manufacturing
Dmx Pharma's top competitors are
Alfa Omega Srl,
Ibsa Italy,
Chiesi Group,
Alfasigma,
Mipharm Spa,
Azzurra Capital,
Indena,
Bsp Pharmaceuticals S.p.a.,
Olon,
Doppel Farmaceutici.
Dmx Pharma's categories are Pharmaceutical Manufacturing
Dmx Pharma's founding year is 2024
